The three cancers with the highest KRAS mutation rates are pancreatic ductal adenocarcinoma (PDA; > 95%), non-small cell lung cancer (NSCLC), and colorectal carcinoma (CRC; 40%) 74. Here, KRAS is linked to non-small cell lung carcinoma.